U-M dementia study named to journal’s top 10 list

March 18, 2013

Journal Watch Psychiatry has named a University of Michigan Health System study as one of the top 10 stories of 2012.

The study – whose lead author is Helen C. Kales, M.D., associate professor of psychiatry at the U-M Medical School and researcher at the VA Ann Arbor Healthcare System – evaluated how antipsychotics affect mortality risk in dementia patients. The study found that risks varied. While Haloperidol had the highest 6-month mortality rate, quetiapine had the lowest.

Journal Watch condenses summaries of key research across specialties, including Psychiatry, from more than 250 medical journals into concise yet comprehensive articles, incorporating clinical commentary from prominent physician-editors in the field.

According to the website, editors chose the top 10 stories in the field of Psychiatry “with an eye toward relevance to clinical practice.”

Of the articles picked, editors said “Overall, the stories highlight a continuing problem for both treatment researchers and the patients hoping to benefit from this research: The paucity of studies examining how best to treat patients who have not benefitted from an initial (or several initial) courses of treatment.”

For more on the top 10 stories, visit the website: http://psychiatry.jwatch.org/cgi/content/full/2012/1228/1.